Conditions: Glioblastoma
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 28
Healthy volunteers: no

Brief summary:
To determine whether dasatinib plus lomustine are effective for treatment of recurrent glioblastoma

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: Dasatinib intervention 2: Lomustine
Intervention descriptions: intervention 1: Tablets, Oral, 100 mg, Once or Twice daily (depending on safety cohort), Until progression or toxicity intervention 2: Tablets, Oral, 110 mg/m², Every 6 weeks, until progression or toxicity

Protocol document: